All Stories

  1. The carcinogenic risks in coffee (case study: Lebanese population)

    Article • Chemosphere, October 2018, Elsevier

    Martine I Abboud

  2. Publisher Correction: The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases

    Article • Nature Methods, June 2018, Springer Science + Business Media

    Martine I Abboud

  3. The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases

    Article • Nature Methods, June 2018, Springer Science + Business Media

    Martine I Abboud

  4. The role of K241 in KDM4 catalysis

    Article • ChemBioChem, February 2018, Wiley

    Martine I Abboud

  5. 2OG regulates binding of hydroxylated HIF to PHD2

    Article • Chemical Communications, January 2018, Royal Society of Chemistry

    Martine I Abboud, Prof. Dr. Jasmin Mecinovic

  6. Non-competitive cyclic peptides for targeting enzyme–substrate complexes

    Article • Chemical Science, January 2018, Royal Society of Chemistry

    Martine I Abboud

  7. In silico fragment based design leads to B1 metallo-β-lactamase inhibitors

    Article • Journal of Medicinal Chemistry, December 2017, American Chemical Society (ACS)

    Martine I Abboud

  8. Cyclobutanones mimic the intermediates in metallo-β-lactamase catalysis

    Article • Chemistry - A European Journal, December 2017, Wiley

    Martine I Abboud

  9. Structural and stereoelectronic insights into oxygenase-catalyzed formation of ethylene from 2-oxoglutarate

    Article • Proceedings of the National Academy of Sciences, April 2017, Proceedings of the National Academy of Sciences

    Martine I Abboud

  10. 19 F-NMR Reveals the Role of Mobile Loops in Product and Inhibitor Binding by the São Paulo Metallo-β-Lactamase

    Article • Angewandte Chemie International Edition, March 2017, Wiley

    Martine I Abboud

  11. NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors

    Article • Chemical Science, January 2017, Royal Society of Chemistry

    Martine I Abboud

  12. Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition

    Article • Chemical Communications, January 2017, Royal Society of Chemistry

    Martine I Abboud

  13. Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials

    Article • Chemical Science, January 2017, Royal Society of Chemistry

    Martine I Abboud

  14. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases

    Article • Nature Communications, August 2016, Springer Science + Business Media

    Martine I Abboud

  15. Amifostine radioprotects normal tissue via Warburg-type effects

    Article • Scientific Reports, August 2016, Springer Science + Business Media

    Martine I Abboud

  16. Interaction of Avibactam with Class B Metallo-β-Lactamases

    Article • Antimicrobial Agents and Chemotherapy, July 2016, ASM Journals

    Martine I Abboud, Professor Jean-Marie A FRERE, Christopher Schofield

  17. The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam

    Article • Future Medicinal Chemistry, June 2016, Future Science

    Martine I Abboud

  18. Targeting Protein-Protein Interactions in the HIF System

    Article • ChemMedChem, March 2016, Wiley

    Martine I Abboud

  19. Comparison of Verona Integron-Borne Metallo-β-Lactamase (VIM) Variants Reveals Differences in Stability and Inhibition Profiles

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Professor CEMAL SANDALLI, Martine I Abboud, Christopher Schofield

  20. Carcinogenic and neurotoxic risks of acrylamide and heavy metals from potato and corn chips consumed by the Lebanese population

    Article • Journal of Food Composition and Analysis, September 2015, Elsevier

    Martine I Abboud, Sally Demirdjian